This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Multi-target incretin-based therapeutics: The rise of dual and triple agonists for metabolic disorders.
European journal of medicinal chemistry, 305, 118587
Citation
Alavi, Seyed Ebrahim; Boshrouyeh, Reza; Raza, Aun; Ebrahimi Shahmabadi, Hasan. (2026). Multi-target incretin-based therapeutics: The rise of dual and triple agonists for metabolic disorders.. European journal of medicinal chemistry, 305, 118587. https://doi.org/10.1016/j.ejmech.2026.118587